Science Explorer Back to mapMap

Most cited papers from Adamas Pharmaceuticals (United States)

What are the most cited papers from Adamas Pharmaceuticals (United States)?

The most cited paper from Adamas Pharmaceuticals (United States) is "Loss of PTEN facilitates HIF-1-mediated gene expression" (WAYNE S. ZUNDEL, Cornelia Schindler, Daphne Adele Haas-Kogan et al., 2000), with 836 citations. Next come "Requirements for high impact diagnostics in the developing world" (604) and "Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality." (601).

Showing 50 of 60 papers. Every paper with more than 21 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Loss of PTEN facilitates HIF-1-mediated gene expression WAYNE S. ZUNDEL, Cornelia Schindler, Daphne Adele Haas-Kogan et al. · Genes & Development Open access 15 Feb 2000 836
2 Requirements for high impact diagnostics in the developing world Mickey S. Urdea, Laura Penny, Stuart S. Olmsted et al. · Nature Nov 2006 604
3 Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Laurie Stephens, Ann E. Sutherland, Irina V. Klimanskaya et al. · Genes & Development Open access Aug 1995 601
4 Detection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial Lesions Kao‐Lee Liaw, A. G. Glass, M. Michele Manos et al. · JNCI Journal of the National Cancer Institute 2 Jun 1999 251
5 HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1 Kenji Uchimura, Megumi Morimoto‐Tomita, Annette Bistrup et al. · BMC Biochemistry Open access 17 Jan 2006 220
6 Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance Daina Zeng, Dmitri V. Debabov, Theresa L. Hartsell et al. · Cold Spring Harbor Perspectives in Medicine Open access 23 Sep 2016 213
7 Syk Is Activated by Phosphotyrosine-containing Peptides Representing the Tyrosine-based Activation Motifs of the High Affinity Receptor for IgE Lily Shiue, Mark J. Zoller, Joan S. Brugge · Journal of Biological Chemistry Open access May 1995 202
8 Isoprenoid modification of rab proteins terminating in CC or CXC motifs. Roya Khosravi‐Far, Robert J. Lutz, Adrienne D. Cox et al. · Proceedings of the National Academy of Sciences Open access 15 Jul 1991 179
9 Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro Jack T Nguyen, Justin D. Hoopes, Minh Ha Le et al. · PLoS ONE Open access 19 Feb 2010 176
10 Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial Stephen E. Straus, Anna Wald, Rhonda G. Kost et al. · The Journal of Infectious Diseases Open access Nov 1997 170
11 Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3) Wolfgang Hermann Oertel, Karla Maria Eggert, Rajesh Pahwa et al. · Movement Disorders Open access 21 Aug 2017 168
12 Modeling amantadine treatment of influenza A virus in vitro Catherine A. A. Beauchemin, James J. McSharry, George L. Drusano et al. · Journal of Theoretical Biology Open access 31 May 2008 158
13 Sulf-2, a Proangiogenic Heparan Sulfate Endosulfatase, Is Upregulated in Breast Cancer Megumi Morimoto‐Tomita, Kenji Uchimura, Annette Bistrup et al. · Neoplasia Open access Nov 2005 157
14 Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study) Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser et al. · Movement Disorders Open access 4 Feb 2015 153
15 Disease-specific non–reducing end carbohydrate biomarkers for mucopolysaccharidoses Roger Lawrence, Jillian R.-M. Brown, Kanar Al-Mafraji et al. · Nature Chemical Biology Open access 8 Jan 2012 149
16 Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Nikolaos K. R K Robakis, P R Sawh, Gloria C. Wolfe et al. · Proceedings of the National Academy of Sciences Open access Sep 1986 126
17 microbeMASST: a taxonomically informed mass spectrometry search tool for microbial metabolomics data Simone Zuffa et al. · Nature Microbiology Open access109 authors 5 Feb 2024 125
18 Physiological variant of antithrombin‐III lacks carbohydrate sidechain at Asn 135 Stephen O. Brennan, Peter M. George, Robert E. Jordan · FEBS Letters 27 Jul 1987 114
19 Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial John H Beigel et al. · The Lancet Infectious Diseases Open access 23 Sep 2017 101
20 Thermodynamic benchmark study using Biacore technology Iva Hopkins Navratilova et al. · Analytical Biochemistry Open access 27 Jan 2007 101
21 A global benchmark study using affinity-based biosensors Rebecca L. Rich et al. · Analytical Biochemistry Open access151 authors 28 Nov 2008 99
22 Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study Quan Dong Nguyen, Mohamed Abdellah Ibrahim, Anthony Watters et al. · Journal of Ophthalmic Inflammation and Infection Open access 2013 97
23 Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses Jack T Nguyen, Donald F. Smee, Dale L. Barnard et al. · PLoS ONE Open access 23 Jan 2012 91
24 Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE Nathalie Gaspar et al. · Annals of Oncology Open access 11 Jan 2018 79
25 Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors. Craig R. Brunetti, Rae Lyn Burke, Stuart Kornfeld et al. · Journal of Biological Chemistry Open access Jun 1994 78
26 Sulfotransferase structural biology and inhibitor discovery Virginia L. Rath, Dawn E. Verdugo, Stefan Hemmerich · Drug Discovery Today Dec 2004 74
27 Epidemiologic Determinants of Seroreactivity to Human Papillomavirus (HPV) Type 16 Virus-Like Particles in Cervical HPV-16 DNA--Positive and --Negative Women Louise Wideroff, Mark H. Schiffman, Robert N. Hoover et al. · The Journal of Infectious Diseases Open access Nov 1996 71
28 Combination Therapy with Amantadine, Oseltamivir and Ribavirin for Influenza a Infection: Safety and Pharmacokinetics Sachiko Seo, Janet A. Englund, Jack T Nguyen et al. · Antiviral Therapy Open access 21 Dec 2012 70
29 Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70. Jack H. Nunberg, G Rodgers, James H. Gilbert et al. · Proceedings of the National Academy of Sciences Open access Jun 1984 69
30 Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease Lawrence W. Elmer, Jorge L. Juncos, Carlos Singer et al. · CNS Drugs Open access 12 Mar 2018 62
31 Amantadine Improves Cognitive Outcome and Increases Neuronal Survival after Fluid Percussion Traumatic Brain Injury in Rats Tao Wang, Xian-jian Huang, Ken C. Van et al. · Journal of Neurotrauma 10 Apr 2013 61
32 In Vivo Replication Capacity Rather Than In Vitro Macrophage Tropism Predicts Efficiency of Vaginal Transmission of Simian Immunodeficiency Virus or Simian/Human Immunodeficiency Virus in Rhesus Macaques Christopher J. Miller, Marta L. Marthas, Jennifer L. Greenier et al. · Journal of Virology Open access Apr 1998 59
33 Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus Justin D. Hoopes, Elizabeth M. Driebe, Erin Kelley et al. · PLoS ONE Open access 29 Dec 2011 57
34 ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study Robert A. Hauser, Rajesh Pahwa, Caroline M. Tanner et al. · Journal of Parkinson s Disease Open access 4 Aug 2017 52
35 ACCELERATE – Five years accelerating cancer drug development for children and adolescents Andrew D.J. Pearson et al. · European Journal of Cancer Open access 12 Mar 2022 50
36 Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia Robert A. Hauser, Rajesh Pahwa, William A. Wargin et al. · Clinical Pharmacokinetics Open access 18 May 2018 46
37 The human genes for hemophilia A and hemophilia B flank the X chromosome fragile site at Xq27.3. Michele Purrello, Becky Alhadeff, Diane Esposito et al. · The EMBO Journal Open access Mar 1985 46
38 Preliminary Results of the Use of a Stabilized Hypochlorous Acid Solution in the Management of Ralstonia Pickettii Biofilm on Silicone Breast Implants C. Tod Brindle, Steve L. Porter, Kiran Bijlani et al. · Aesthetic Surgery Journal 12 Dec 2017 45
39 Strategies for drug discovery by targeting sulfation pathways Stefan Hemmerich, Dawn E. Verdugo, Virginia L. Rath · Drug Discovery Today Nov 2004 44
40 Subxyphoid access of the normal pericardium: A novel drug delivery technique Roger J. Laham, Michael Simons, David Wei Loong Hung · Catheterization and Cardiovascular Interventions May 1999 43
41 Striatal Kir2 K+ channel inhibition mediates the antidyskinetic effects of amantadine Weixing Shen, Wenjie Ren, Shenyu Zhai et al. · Journal of Clinical Investigation Open access 19 Apr 2020 41
42 p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling Andreas Sturm, Jugoh Itoh, James W. Jacobberger et al. · Journal of Clinical Investigation Open access Jun 2002 38
43 Syntheses of 6-Sulfo Sialyl Lewis X Glycans Corresponding to the l -Selectin Ligand “Sulfoadhesin” Matthew R. Pratt, Carolyn Ruth Bertozzi · Organic Letters 11 Jun 2004 37
44 Kinetics of 1,2-Dichloroethane and 1,2-Dibromoethane Biodegradation in Anaerobic Enrichment Cultures Rong Yu, Hari Shankar Peethambaram, Ronald W. Falta et al. · Applied and Environmental Microbiology Open access 22 Dec 2012 37
45 Montane Meadows: A Soil Carbon Sink or Source? Cody C. Reed, Amy G. Merrill, W. Mark Drew et al. · Ecosystems 6 Nov 2020 36
46 EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease Caroline M. Tanner, Rajesh Pahwa, Robert A. Hauser et al. · Journal of Parkinson s Disease Open access 17 Jan 2020 36
47 The Pharmacology of Aminoadamantane Nitrates Yuqiang Wang, Jerry P. Eu, Mark S. Washburn et al. · Current Alzheimer Research 17 Jun 2006 35
48 Association of adipose tissue and skeletal muscle metrics with overall survival and postoperative complications in soft tissue sarcoma patients: an opportunistic study using computed tomography Robert Downey Boutin, Jeremy R. Katz, Abhijit J. Chaudhari et al. · Quantitative Imaging in Medicine and Surgery Open access 10 Jul 2020 34
49 Identification of prolipoprotein signal peptidase and genomic organization of the lsp gene in Escherichia coli. Masao Tokunaga, J M Loranger, Sui‐Yuan Chang et al. · Journal of Biological Chemistry Open access May 1985 33
50 Interval Methods for Accelerated Global Search in the Microsoft Excel Solver Ivo P. Nenov, Daniel H. Fylstra · Reliable Computing Apr 2003 33

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.